Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning global outbreak modeling and vector dynamics, novel therapeutic strategies for chronic viral and bacterial infections, and emerging diagnostic and environmental health insights. Let's dive in.

This week's papers:

1. Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study. — The Lancet. Infectious diseases 2026
2. The origin, history, and resistance architecture of an invasive urban malaria mosquito in Africa. — Science 2026
3. A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics. — Nature 2026
4. Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964-2025: Systematic review, meta-analyses, and meta-regressions. — PLoS medicine 2026
5. Klebsiella genus as driver of human disease: from infections to non-communicable disorders. — Nature reviews. Microbiology 2026
6. FDG-PET/CT Demonstrates Superior Detection of Multiorgan Involvement in Paracoccidioidomycosis Compared with Conventional Staging. — Clinical infectious diseases 2026
7. WHO estimates of the global, regional, and national disease burden of nine foodborne chemicals, 2000-21: an updated data synthesis. — The Lancet. Global health 2027
8. Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026
9. Effectiveness of the BNT162b2 LP.8.1-adapted SARS-CoV-2 vaccine against COVID-19-associated hospitalisation and death: a Danish nationwide cohort study. — The Lancet. Infectious diseases 2026
10. An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. — Cell 2026

Listen at AudioScholar